|
|
|
NCCN program on Discovery Health Channel profiles patients undergoing treatment for metastatic breast cancer and their physicians' use of the NCCN
Individual.com · Nov. 21, 2009
|
|
|
|
|
NCCN program on Discovery Health Channel profiles patients undergoing treatment for metastatic breast cancer and their physicians' use of the NCCN
|
|
|
|
|
“Our study found that, for women with hormone receptor-positive metastatic breast cancer, CYP2D6 phenotype, as derived from both genotype
Hemonctoday · Nov. 20, 2009
|
|
|
|
|
135 patients with metastatic breast cancer The significance of the following factors in predicting the survival rate after the occurrence of
MDLinx · Nov. 19, 2009
|
|
|
|
|
... is currently in clinical studies in patients with glioblastoma multiforme and metastatic melanoma. About Metastatic Melanoma Melanoma incidence...
|
|
|
|
|
... of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at...
News-Medical.Net · Nov. 17, 2009
|
|
|
|
|
... release formulation of Decapeptyl® (triptorelin embonate1 22.5 mg) for the treatment of locally advanced and metastatic prostate cancer.
|
|
|
|
|
Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
MDLinx · Nov. 11, 2009
|
|
|
|
|
NCCN program on Discovery Health Channel profiles patients undergoing treatment for metastatic breast cancer and their physicians' use of the NCCN
Nashville Business Journal · Nov. 20, 2009
|
|
|
|
|
NCCN program on Discovery Health Channel profiles patients undergoing treatment for metastatic breast cancer and their physicians' use of the NCCN
Birmingham Business Journal · Nov. 20, 2009
|
|
